295 related articles for article (PubMed ID: 30574853)
21. Molecular Docking Studies and Synthesis of Amino-oxy-diarylquinoline Derivatives as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.
Makarasen A; Kuno M; Patnin S; Reukngam N; Khlaychan P; Deeyohe S; Intachote P; Saimanee B; Sengsai S; Boonsri P; Chaivisuthangkura A; Sirithana W; Techasakul S
Drug Res (Stuttg); 2019 Dec; 69(12):671-682. PubMed ID: 31698495
[TBL] [Abstract][Full Text] [Related]
22. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
[TBL] [Abstract][Full Text] [Related]
23. Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy.
Zeng ZS; He QQ; Liang YH; Feng XQ; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Bioorg Med Chem; 2010 Jul; 18(14):5039-47. PubMed ID: 20598556
[TBL] [Abstract][Full Text] [Related]
24. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents.
Barreca ML; Chimirri A; De Luca L; Monforte AM; Monforte P; Rao A; Zappalà M; Balzarini J; De Clercq E; Pannecouque C; Witvrouw M
Bioorg Med Chem Lett; 2001 Jul; 11(13):1793-6. PubMed ID: 11425562
[TBL] [Abstract][Full Text] [Related]
26. Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase.
Zhu M; Ma L; Wen J; Dong B; Wang Y; Wang Z; Zhou J; Zhang G; Wang J; Guo Y; Liang C; Cen S; Wang Y
Eur J Med Chem; 2020 Jan; 186():111900. PubMed ID: 31771827
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, anti-HIV and antitubercular activities of isatin derivatives.
Sriram D; Yogeeswari P; Meena K
Pharmazie; 2006 Apr; 61(4):274-7. PubMed ID: 16649536
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
30. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
31. Comparative Docking Studies: A Drug Design Tool for Some Pyrazine- Thiazolidinone Based Derivatives for Anti-HIV Activity.
Asgaonkar KD; Patil SM; Chitre TS; Ghegade VN; Jadhav SR; Sande SS; Kulkarni AS
Curr Comput Aided Drug Des; 2019; 15(3):252-258. PubMed ID: 30569873
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors.
Arranz ME; Díaz JA; Ingate ST; Witvrouw M; Pannecouque C; Balzarini J; De Clercq E; Vega S
Bioorg Med Chem; 1999 Dec; 7(12):2811-22. PubMed ID: 10658585
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
Barreca ML; Balzarini J; Chimirri A; De Clercq E; De Luca L; Höltje HD; Höltje M; Monforte AM; Monforte P; Pannecouque C; Rao A; Zappalà M
J Med Chem; 2002 Nov; 45(24):5410-3. PubMed ID: 12431069
[TBL] [Abstract][Full Text] [Related]
34. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs.
Liu Z; Tian Y; Liu J; Huang B; Kang D; De Clercq E; Daelemans D; Pannecouque C; Zhan P; Liu X
Eur J Med Chem; 2017 Nov; 140():383-391. PubMed ID: 28987601
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
[TBL] [Abstract][Full Text] [Related]
37. Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility.
Frączek T; Kamiński R; Krakowiak A; Naessens E; Verhasselt B; Paneth P
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):9-16. PubMed ID: 29098886
[TBL] [Abstract][Full Text] [Related]
38. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
Saharan VD; Mahajan SS
Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
Kang D; Fang Z; Li Z; Huang B; Zhang H; Lu X; Xu H; Zhou Z; Ding X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2016 Sep; 59(17):7991-8007. PubMed ID: 27541578
[TBL] [Abstract][Full Text] [Related]
40. Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Devale TL; Parikh J; Miniyar P; Sharma P; Shrivastava B; Murumkar P
Bioorg Chem; 2017 Feb; 70():256-266. PubMed ID: 28160944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]